Efficacy and Safety of Selective JAK 1 Inhibitor Filgotinib in Active Rheumatoid Arthritis Patients With Inadequate Response to Methotrexate: Comparative Study With Filgotinib and Tocilizumab Examined by Clinical Index as Well as Musculoskeletal Ultrasound Assessment
Latest Information Update: 04 Jan 2024
At a glance
- Drugs Filgotinib (Primary) ; Tocilizumab
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- Acronyms TRANSFORM
- 04 Jun 2022 Study design presented at the 23rd Annual Congress of the European League Against Rheumatism
- 29 Oct 2021 New trial record